Author

Patricia Munteanu

University of Duisburg-Essen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Barbara M. GrüneriD· 3 shared Alexander Schramm· 2 shared Anna Baginska· 2 shared Madeleine DorschiD· 2 shared Albert Fradera-SolaiD· 1 shared Albrecht StenzingeriD· 1 shared Alexander R. SchrammiD· 1 shared Balázs HegedűsiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Barbara M. GrünerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Artesunate Exploits Glutathione-Dependent Redox Vulnerability in Metastatic Lung Adenocarcinoma

Patricia Munteanu, Sophia Neuhaus, Paula Feldt, Vahan Serobyan, Anna Baginska, José Pedro Friedmann Angeli, Jürgen Becker, Alexander Schramm, Barbara M. Grüner

This study identifies artesunate as a drug that targets redox vulnerabilities in metastatic lung adenocarcinoma by exploiting glutathione-dependent mechanisms.

bioRxiv · Oct 7, 2026 · PreprintCancer Biology

Loss of the Y chromosome drives epigenetic and transcriptomic plasticity in lung adenocarcinoma

Kathleen Schlüter, Mei-Ju May Chen, Gizem Altun, Sergio Manzano-Sanchez, Dung-Chi Wu, Nan Zhang, Ofir Griess, Luc Husemann, Fabian Bradic, Joseph Cornick, Nima Esmaeelpour, Oliver Mücke, Riccardo Moro, Katherine Kelly, Sara Chocarro, , Maria Llamazares Prada

This study shows that loss of the Y chromosome in lung adenocarcinoma causes epigenetic and transcriptomic changes that increase lineage plasticity and poor clinical outcomes.

bioRxiv · Jun 5, 2026 · PreprintCancer Biology

Quantifying Treatment Resistance in Mixtures of Gastrointestinal Stromal Tumor Cells with BARMIX

Mohammad Darbalaei, Thomas Mühlenberg, Julia Zummack, Philip Dujardin, Susanne Grünewald, Anna Baginska, Patricia Munteanu, Marina Martinez Cruz, Madeleine Dorsch, Alexander R. Schramm, Sebastian Bauer, Daniel E. Hoffmann, Barbara M. Grüner

BARMIX quantifies treatment resistance in gastrointestinal stromal tumor cell mixtures using barcoded experiments and probabilistic modeling, accurately reflecting clinical resistance patterns.

bioRxiv · Mar 25, 2026 · PreprintSystems Biology